Skip to main content

Table 2 Nicotinamide adenine dinucleotide phosphate oxidase subunit protein expression in neutrophils and monocytes

From: Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet’s disease

Cell source

Stimulus

None

PMA

HC plasma

iBD plasma

aBD plasma

Neutrophils

 gp91-phox

  HC

23.98 ± 11.55

399.71 ± 47.86a

148.26 ± 29.29

261.27 ± 32.52b

271.33 ± 44.23b

  iBD

19.66 ± 11.23

402.00 ± 71.57a

156.95 ± 31.23

291.87 ± 45.39b

297.35 ± 22.48b

  aBD

32.68 ± 17.61

464.71 ± 48.45a

139.05 ± 32.75

277.88 ± 41.76b

278.64 ± 39.95b

 p22

  HC

20.93 ± 11.40

453.04 ± 70.51a

139.25 ± 31.37

262.56 ± 36.43b

281.02 ± 53.86b

  iBD

23.72 ± 12.25

438.87 ± 52.98a

132.62 ± 17.28

279.12 ± 38.67b

282.62 ± 35.75b

  aBD

38.82 ± 24.88

422.75 ± 64.76a

152.78 ± 9.32

288.74 ± 30.77b

314.94 ± 40.60b

 p40

  HC

22.73 ± 9.96

377.33 ± 115.38a

165.77 ± 33.20

279.88 ± 38.13b

299.00 ± 49.97b

  iBD

42.43 ± 7.36

453.37 ± 77.82a

133.37 ± 16.08

279.00 ± 50.57b

293.12 ± 31.47b

  aBD

28.85 ± 12.85

475.42 ± 79.97a

160.71 ± 20.86

274.71 ± 55.96b

253.00 ± 36.56b

 p47

  HC

22.16 ± 9.23

383.05 ± 69.88a

132.90 ± 38.84

247.97 ± 92.38b

280.63 ± 59.20b

  iBD

35.68 ± 22.66

447.75 ± 41.11a

151.53 ± 29.26

274.12 ± 50.08b

270.12 ± 56.07b

  aBD

21.04 ± 7.94

400.00 ± 57.01a

141.27 ± 34.16

282.12 ± 16.01b

293.00 ± 50.48b

 p67

  HC

32.78 ± 13.00

487.36 ± 93.67a

162.11 ± 32.10

288.44 ± 42.48b

296.11 ± 55.36b

  iBD

36.61 ± 15.39

396.50 ± 57.82a

145.12 ± 30.69

289.50 ± 46.72b

266.12 ± 54.21b

  aBD

26.42 ± 9.91

425.42 ± 50.71a

160.00 ± 22.37

296.71 ± 42.42b

274.57 ± 39.45b

Monocytes

 gp91-phox

  HC

29.75 ± 16.20

412.02 ± 68.52a

154.13 ± 19.00

355.05 ± 107.18b

421.50 ± 78.28b

  iBD

16.43 ± 5.38

415.43 ± 60.54a

148.00 ± 33.64

318.06 ± 17.94b

330.40 ± 15.98b

  aBD

22.41 ± 8.09

468.62 ± 30.17a

149.41 ± 26.47

263.51 ± 50.51b

282.71 ± 50.99b

 p22

  HC

21.37 ± 12.57

486.14 ± 82.35a

157.44 ± 40.22

267.42 ± 34.51b

281.82 ± 39.82b

  iBD

23.00 ± 14.07

442.61 ± 44.55a

157.41 ± 30.28

281.65 ± 35.56b

283.66 ± 43.68b

  aBD

27.25 ± 21.68

414.80 ± 33.12a

129.20 ± 15.01

272.47 ± 29.72b

235.70 ± 53.94b

 p40

  HC

28.21 ± 10.94

467.00 ± 67.57a

147.22 ± 25.00

286.11 ± 37.36b

273.77 ± 53.97b

  iBD

54.53 ± 6.55

560.12 ± 74.73a

142.25 ± 30.90

259.25 ± 42.82b

289.25 ± 35.70b

  aBD

45.62 ± 9.24

468.75 ± 78.34a

137.00 ± 25.80

290.37 ± 31.87b

301.25 ± 44.61b

 p47

  HC

27.45 ± 11.87

387.52 ± 45.42a

155.84 ± 17.92

246.52 ± 37.54b

263.57 ± 60.32b

  iBD

23.56 ± 15.99

416.77 ± 49.75a

118.50 ± 27.70

278.71 ± 35.03b

286.70 ± 49.01b

  aBD

29.49 ± 23.42

427.37 ± 63.68a

160.71 ± 24.88

264.12 ± 21.63b

262.01 ± 38.54b

 p67

  HC

27.09 ± 17.14

453.77 ± 62.69a

160.44 ± 27.99

272.55 ± 42.45b

275.22 ± 46.01b

  iBD

29.01 ± 12.42

420.12 ± 71.30a

140.37 ± 26.73

281.75 ± 38.49b

303.75 ± 48.17b

  aBD

29.41 ± 12.61

447.00 ± 67.93a

142.50 ± 34.80

249.75 ± 39.07b

269.50 ± 33.04b

  1. Abbreviations: aBD Active Behçet’s disease, HC Healthy control, iBD Inactive Behçet’s disease, PMA Phorbol 12-myristate 13-acetate
  2. Neutrophils and monocytes were obtained from HCs (n = 9), patients with iBD (n = 8), and patients with aBD (n = 8), and protein expression as determined by mean fluorescence intensity was found to be increased after stimulation with BD plasma
  3. Statistical analysis was performed using one-way analysis of variance with the Bonferroni posttest
  4. a p < 0.05 compared with unstimulated cells and any other stimulus
  5. b p < 0.05 compared with unstimulated cells and stimulation with plasma from HCs